Calithera Biosciences Inc CALA

NAS: CALA | ISIN: US13089P1012 14/11/2024

0,007 USD (+16,67%)

(+16,67%) 14/11/2024

Grafiek Calithera Biosciences Inc

Grafiek Calithera Biosciences Inc

1 dag1d 16,67%
1 week1w 16,67%
1 maand1m 600,00%
3 maanden3m -44,00%
6 maanden6m -65,00%
1 jaar1j -76,67%
5 jaar5j -99,80%

Calithera Biosciences Inc in het nieuws

Toon enkel gratis nieuws

7 januari 2022 · AN2 Therapeutics Closed $80 Million Series B Financing to Advance Novel Nontuberculous Mycobacterial Lung Disease Program · Persbericht

16 maart 2021 · Calithera Biosciences Reports Fourth Quarter 2020 Financial Results and Recent Highlights · Persbericht

12 maart 2021 · UPDATE – Calithera Biosciences to Report Fourth Quarter 2020 Financial Results on Tuesday, March 16, 2021 · Persbericht

10 maart 2021 · Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021 · Persbericht

11 januari 2021 · INCB001158 Biliary Tract Cancer Data to be Presented at 2021 Virtual ASCO Gastrointestinal Cancers Symposium · Persbericht

5 januari 2021 · Calithera to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference · Persbericht

4 januari 2021 · Calithera Biosciences Reports CANTATA Study of Telaglenastat in Renal Cell Carcinoma Did Not Achieve Primary Endpoint · Persbericht

Profiel Calithera Biosciences Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.calithera.com

Hoofdzetel: South San Francisco, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe